PABLO MARTINEZ CAMBLOR-rekin lankidetzan egindako argitalpenak (4)

2016

  1. Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: The authors' reply

    Leukemia

2015

  1. Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: Results from the Spanish registry

    Leukemia, Vol. 29, Núm. 9, pp. 1875-1881

2013

  1. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  2. Survival of hematological patients after discharge from the intensive care unit: A prospective observational study

    Critical Care, Vol. 17, Núm. 6